By WSJ Staff
Apple $(AAPL)$: The company's net income beat expectations, despite iPhone sales falling in the crucial December quarter. Shares climbed more than 3% in premarket trading.
Intel $(INTC)$: The chip-maker reported a smaller-than-expected decline in quarterly sales, alongside a gloomy outlook. The stock rose almost 2% premarket.
Visa (V): The credit-card company's earnings and revenue outstripped estimates, with Visa citing strong spending during the holiday season. The stock gained 2% before the opening bell.
Vertex Pharmaceuticals $(VRTX)$: Shares in the biopharmaceutical company shot up almost 10% offhours after the Food and Drug Administration approved Vertex's oral non-opioid pain medication, Journavx.
Samsung (KR:005930): The world's largest maker of memory chips and smartphones forecast limited earnings growth in this quarter due to weakening profits in its core semiconductor sector. Samsung shares fell 2.4% in South Korea.
Novartis (CH:NOVN, NVS): The pharmaceutical company forecast further profit and sales growth this year, after beating fourth-quarter expectations. Shares rose 3.5% in Switzerland.
AbbVie $(ABBV)$, Chevron $(CVX)$, Colgate-Palmolive $(CL)$ and Exxon Mobil $(XOM)$ are scheduled to report earnings before U.S. markets open today.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
January 31, 2025 04:59 ET (09:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。